Discover 158 paid clinical trials in Reno, Nevada. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 158
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Reno NV, Oakland CA, Madera CA, San Francisco CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 3 - 29
Code: NCT04684368
Phase 2, Recruiting
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Location: Reno NV, Rocklin CA, Carmichael CA, Sacramento CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 5 - 60
Code: NCT05675410
Phase 3, Recruiting
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
for
Locally Advanced Lung Non-Small Cell Carcinoma,
Location: Reno NV, Roseville CA, Marysville CA, Sacramento CA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05624996
Phase 3, Recruiting
Project: Every Child for Younger Patients With Cancer
for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Reno NV, Sacramento CA, Oakland CA, Madera CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 25
Code: NCT02402244
Recruiting
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
for
Cigarette Smoking-Related Carcinoma
Location: Reno NV, Carson City NV, St. Helena CA, Kingman AZ,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT05008848
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
for
Metastatic Colorectal Adenocarcinoma,
Location: Reno NV, Bend OR, Nampa ID, Meridian ID, Boise ID,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT05673148
Phase 2, Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Reno NV, Sacramento CA, Oakland CA, Madera CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase 3, Recruiting
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
for
Non Small Cell Lung Cancer
Location: Reno NV, San Francisco CA, Los Angeles CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312137
Phase 3, Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Location: Reno NV, Fremont CA, Fresno CA, San Francisco CA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT06072482
Phase 4, Recruiting
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
for
Relapsed/Refractory Multiple Myeloma (RRMM)
Location: Reno NV, Los Angeles CA, Tacoma WA, Lubbock TX,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07609940
Phase 4, Recruiting
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Reno NV, Long Beach CA, Portland OR, Olympia WA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05947851
Phase 3, Recruiting
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Reno NV, Burbank CA, Corvallis OR, Phoenix AZ,
Location: Reno NV, Sacramento CA, Meridian ID, Northridge CA,
Sponsor: Apollo Therapeutics Ltd
Sex: All
Age: 18 - 65
Code: NCT07599813
Phase 2, Recruiting
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
for
Alopecia Areata
Location: Reno NV, Sacramento CA, Las Vegas NV, Thousand Oaks CA,
Sponsor: AbbVie
Sex: All
Age: 12 - 63
Code: NCT06012240
Phase 3, Recruiting
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for
HER2-positive Gastric Cancer,
Location: Reno NV, Walnut Creek CA, Solvang CA, Santa Monica CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06764875
Phase 3, Recruiting
Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
for
Thyroid Eye Disease, TED, Graves Orbitopathy
Location: Las Vegas NV, Reno NV, San Francisco CA, Canoga Park CA,
Sponsor: Sling Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07753603
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Migraine
Location: Reno NV, Walnut Creek CA, Las Vegas NV,
Sponsor: TriGemX Bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07645924
Phase 3, Recruiting
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
for
Chronic Idiopathic Constipation (CIC)
Location: Reno NV, Lincoln CA, San Jose CA, Boise ID,